GalNAc-T2, soluble fragment, Human Recombinant

GalNAc-T2, soluble fragment, Human Recombinant is available at Gentaur for Next week delivery.

Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis

Biomolecule/Target: GALNT2

Alternates names: Polypeptide N-acetylgalactosaminyltransferase 2, Polypeptide GalNAc transferase 2, GaNTase 2

Synonyms: Polypeptide N-acetylgalactosaminyltransferase 2, Polypeptide GalNAc transferase 2, GaNTase 2

Background Information: Polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) catalyzes the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the hydroxyl group of serine and threonine residues. Twenty GalNAc-T genes have been identified in humans and most have been shown to represent active GalNAc-Ts. All isoforms are type II transmembrane proteins, with different but partly overlapping substrate preferences. The GalNAc-Ts control the initiation of mucin-type O-linked glycosylation and determine the location and density of O-glycans in a protein. Addition of GalNAc to an unglycosylated Ser/Thr residue creates the Tn antigen GalNAca1-S/T, and subsequent addition of sialic acid by ST6GalNAc-I forms the cancer associated STn antigen. GalNAc-T2 is primarily located in Golgi, and is widely distributed in human tissues.

Reconstitution Instructions: N/A

NCBI Gene Symbol: GALNT2

Gene ID: 2590

NCBI Accession: Q10471